OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mild chronic graft‐versus‐host disease may alleviate poor prognosis associated with FLT 3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete remission: a retrospective study
Barbara Nasiłowska‐Adamska, Anna Czyż, Mirosław Markiewicz, et al.
European Journal Of Haematology (2015) Vol. 96, Iss. 3, pp. 236-244
Open Access | Times Cited: 9
Barbara Nasiłowska‐Adamska, Anna Czyż, Mirosław Markiewicz, et al.
European Journal Of Haematology (2015) Vol. 96, Iss. 3, pp. 236-244
Open Access | Times Cited: 9
Showing 9 citing articles:
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun, et al.
Nature Medicine (2018) Vol. 24, Iss. 3, pp. 282-291
Open Access | Times Cited: 252
Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun, et al.
Nature Medicine (2018) Vol. 24, Iss. 3, pp. 282-291
Open Access | Times Cited: 252
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation
Jenny N. H. G. Ho, Dominik Schmidt, Theresa Lowinus, et al.
Blood (2022) Vol. 140, Iss. 10, pp. 1167-1181
Open Access | Times Cited: 39
Jenny N. H. G. Ho, Dominik Schmidt, Theresa Lowinus, et al.
Blood (2022) Vol. 140, Iss. 10, pp. 1167-1181
Open Access | Times Cited: 39
Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukaemia undergoing allogeneic stem cell transplantation
Philipp Hemmati, Lam G. Vuong, Theis H. Terwey, et al.
European Journal Of Haematology (2016) Vol. 98, Iss. 2, pp. 160-168
Closed Access | Times Cited: 9
Philipp Hemmati, Lam G. Vuong, Theis H. Terwey, et al.
European Journal Of Haematology (2016) Vol. 98, Iss. 2, pp. 160-168
Closed Access | Times Cited: 9
Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor
Toshihiko Ando, Haruna Sano, Masako Yokoo, et al.
International Journal of Hematology (2020) Vol. 112, Iss. 2, pp. 249-253
Closed Access | Times Cited: 5
Toshihiko Ando, Haruna Sano, Masako Yokoo, et al.
International Journal of Hematology (2020) Vol. 112, Iss. 2, pp. 249-253
Closed Access | Times Cited: 5
BCRP mRNA and FLT3‐ITD are independent poor risk factors in adult patients with acute myeloid leukemia and intermediate or normal karyotype
Barbara Nasiłowska‐Adamska, Krzysztof Warzocha, Iwona Solarska, et al.
European Journal Of Haematology (2017) Vol. 99, Iss. 3, pp. 255-261
Closed Access | Times Cited: 4
Barbara Nasiłowska‐Adamska, Krzysztof Warzocha, Iwona Solarska, et al.
European Journal Of Haematology (2017) Vol. 99, Iss. 3, pp. 255-261
Closed Access | Times Cited: 4
Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia
Nadja Hilger, Claudia Mueller, Lilly Stahl, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 3
Nadja Hilger, Claudia Mueller, Lilly Stahl, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 3
Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome
Pavel Jindra, Luděk Raida, Michal Karas, et al.
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 7, pp. 462-469
Closed Access | Times Cited: 3
Pavel Jindra, Luděk Raida, Michal Karas, et al.
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 7, pp. 462-469
Closed Access | Times Cited: 3
FLT3-ITD Allelic Ratio and NPM1 Mutation Do Not Impact Outcomes in Acute Myeloid Leukemia Patients with FLT3-ITD after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Propensity Score- Matching Study
Cuiyan Zhou, Fengmei Zheng, Lan‐Ping Xu, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 7, pp. 456.e1-456.e11
Open Access | Times Cited: 1
Cuiyan Zhou, Fengmei Zheng, Lan‐Ping Xu, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 7, pp. 456.e1-456.e11
Open Access | Times Cited: 1
Targeted Therapy to Trigger GVL: A Case for the Prosecution in FLT3-ITD–Mutant AML
Andrew W. Roberts
The Hematologist (2018) Vol. 15, Iss. 3
Open Access
Andrew W. Roberts
The Hematologist (2018) Vol. 15, Iss. 3
Open Access
